BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1720884)

  • 21. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
    Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
    Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of coagulation and fibrinolytic systems following stroke.
    Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
    Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet activation and fibrinolysis in large bowel cancer.
    Abbasciano V; Bianchi MP; Trevisani L; Sartori S; Gilli G; Zavagli G
    Oncology; 1995; 52(5):381-4. PubMed ID: 7637955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
    Douglas JT; Lowe GD; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical tests on the diagnosis of thrombosis].
    Yamanaka M
    Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of Tennessee antigen, carcinoembryonic antigen, tissue polypeptide antigen and alpha-feto-protein in body fluids associated with pregnancy.
    Oehr P; Bellmann O; Hamann D
    Clin Biochem; 1982 Feb; 15(1):13-6. PubMed ID: 6175441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre- and postsurgery activation of blood coagulation in gastric and large bowel cancers: diagnostic, therapeutic and prognostic hints.
    Abbasciano V; Guerra S; Reali MG; Guglielmini C
    Oncology; 1990; 47(3):261-6. PubMed ID: 2140440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated tumor markers in hemodialysis patients.
    Walz G; Kunzendorf U; Keller F; Fitzner R; Offermann G
    Am J Nephrol; 1988; 8(3):187-9. PubMed ID: 2467561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular markers of hemostasis activation in nephrotic syndrome.
    Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
    Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Thromboglobulin and platelet-factor 4 in patients with cancer: correlation with the stage of disease and the effect of chemotherapy.
    Al-Mondhiry H
    Am J Hematol; 1983 Apr; 14(2):105-11. PubMed ID: 6188373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet and coagulation factors in proliferative diabetic retinopathy.
    Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
    J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor markers. Current use in antineoplastic strategy].
    Manguso L; Musset M; Coraggio F; Grimaldi G; Zito GA; Gattoni A; Catalano G; Astarita C; Papaleo G; Di Domenico M
    Clin Ter; 1984 Aug; 110(3):231-41. PubMed ID: 6207976
    [No Abstract]   [Full Text] [Related]  

  • 35. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever.
    Rao AK; Schapira M; Clements ML; Niewiarowski S; Budzynski AZ; Schmaier AH; Harpel PC; Blackwelder WC; Scherrer JR; Sobel E
    N Engl J Med; 1988 Apr; 318(16):1021-8. PubMed ID: 2965302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor markers in pancreatic cancer.
    Holyoke ED; Douglass HO; Goldrosen MH; Chu TM
    Semin Oncol; 1979 Sep; 6(3):347-56. PubMed ID: 92054
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO
    Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypercoagulation and recurrence of cerebral infarct].
    Landi GL; Anzalone N; Morabito A; D'Angelo A; Mannucci PM
    G Clin Med; 1989; 70(6-7):415-6, 418-9. PubMed ID: 2527773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.
    Librenti MC; D'Angelo A; Micossi P; Garimberti B; Mannucci PM; Pozza G
    Acta Diabetol Lat; 1985; 22(1):39-45. PubMed ID: 2408434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
    Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG
    Oncology; 1989; 46(6):381-5. PubMed ID: 2479897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.